Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 9630

1.

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer.

Masuda N, Ohtani S, Takano T, Inoue K, Suzuki E, Nakamura R, Bando H, Ito Y, Ishida K, Yamanaka T, Kuroi K, Yasojima H, Kasai H, Takasuka T, Sakurai T, Kataoka TR, Morita S, Ohno S, Toi M.

Breast Cancer Res Treat. 2020 Jan 17. doi: 10.1007/s10549-020-05524-6. [Epub ahead of print]

PMID:
31953696
2.

Synthesis of Oligonucleotides Containing 2'-N-alkylaminocarbonyl-2'-amino-LNA (2'-urea-LNA) Moieties Using Post-Synthetic Modification Strategy.

Yamashita S, Nishida K, Osawa T, Nakanishi A, Ito Y, Hari Y.

Molecules. 2020 Jan 15;25(2). pii: E346. doi: 10.3390/molecules25020346.

3.

Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130).

Iwata H, Inoue K, Kaneko K, Ito Y, Tsugawa K, Hasegawa A, Nakagawa S, Kuratomi H, Tamura K.

Jpn J Clin Oncol. 2020 Jan 17. pii: hyz208. doi: 10.1093/jjco/hyz208. [Epub ahead of print] No abstract available.

PMID:
31950142
4.

Refinement for single-nanoparticle structure determination from low-quality single-shot coherent diffraction data.

Nishiyama T, Niozu A, Bostedt C, Ferguson KR, Sato Y, Hutchison C, Nagaya K, Fukuzawa H, Motomura K, Wada SI, Sakai T, Matsunami K, Matsuda K, Tachibana T, Ito Y, Xu W, Mondal S, Umemoto T, Nicolas C, Miron C, Kameshima T, Joti Y, Tono K, Hatsui T, Yabashi M, Ueda K.

IUCrJ. 2020 Jan 1;7(Pt 1):10-17. doi: 10.1107/S2052252519014222. eCollection 2020 Jan 1.

PMID:
31949900
5.

Alterations of brain quantitative proteomics profiling revealed the molecular mechanisms of diosgenin against cerebral ischemia reperfusion effects.

Zhang X, Wang X, Khurm M, Zhan G, Zhang H, Ito Y, Guo Z.

J Proteome Res. 2020 Jan 15. doi: 10.1021/acs.jproteome.9b00667. [Epub ahead of print]

PMID:
31940440
6.

DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.

Krishnan V, Lim DXE, Hoang PM, Srivastava S, Matsuo J, Huang KK, Zhu F, Ho KY, So JBY, Khor C, Tsao S, Teh M, Fock KM, Ang TL, Jeyasekharan AD, Tan P, Yeoh KG, Ito Y.

Gut. 2020 Jan 14. pii: gutjnl-2019-319002. doi: 10.1136/gutjnl-2019-319002. [Epub ahead of print]

PMID:
31937549
7.

A Large Pure Uterine Lipoma: Its Diagnosis by Pelvic MRI and Histopathology.

Calongos G, Ito Y, Kubota Y, Handa M, Ida A, Tsuji Y.

Case Rep Obstet Gynecol. 2019 Dec 21;2019:3929647. doi: 10.1155/2019/3929647. eCollection 2019.

8.

[The Development of the Preoperative Nomogram Predicting Major Perioperative Complications after Radical Cystectomy with Ileal Conduit or Orthotopic Neobladder].

Yamada S, Osawa T, Abe T, Takada N, Matsumoto R, Ito Y, Kikuchi H, Miyajima N, Tsuchiya K, Maruyama S, Murai S, Shinohara N.

Hinyokika Kiyo. 2019 Dec;65(12):495-499. doi: 10.14989/ActaUrolJap_65_12_495. Japanese.

PMID:
31933333
9.

Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).

Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, Nessim SJ, Piraino BM, Pisoni RL, Robinson BM, Schaubel DE, Schreiber MJ, Teitelbaum I, Woodrow G, Zhao J, Johnson DW.

Am J Kidney Dis. 2020 Jan 10. pii: S0272-6386(19)31105-9. doi: 10.1053/j.ajkd.2019.09.016. [Epub ahead of print]

PMID:
31932094
10.

The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem Cells.

Chuang LSH, Osato M, Ito Y.

Mol Cells. 2020 Jan 7. doi: 10.14348/molcells.2019.0250. [Epub ahead of print]

11.

Hypothalamic Contribution to Pituitary Functions Is Recapitulated In Vitro Using 3D-Cultured Human iPS Cells.

Kasai T, Suga H, Sakakibara M, Ozone C, Matsumoto R, Kano M, Mitsumoto K, Ogawa K, Kodani Y, Nagasaki H, Inoshita N, Sugiyama M, Onoue T, Tsunekawa T, Ito Y, Takagi H, Hagiwara D, Iwama S, Goto M, Banno R, Takahashi J, Arima H.

Cell Rep. 2020 Jan 7;30(1):18-24.e5. doi: 10.1016/j.celrep.2019.12.009.

12.

Novel properties of myoferlin in glucose metabolism via pathways involving modulation of adipose functions.

Nozato Y, Takami Y, Yamamoto K, Nagasawa M, Nozato S, Imaizumi Y, Takeshita H, Wang C, Ito Y, Takeda S, Takeya Y, Sugimoto K, Nakagami H, Hanayama R, Rakugi H.

FASEB J. 2020 Jan 7. doi: 10.1096/fj.201901539RR. [Epub ahead of print]

PMID:
31912559
13.

RAMP1 signaling in immune cells regulates inflammation-associated lymphangiogenesis.

Tsuru S, Ito Y, Matsuda H, Hosono K, Inoue T, Nakamoto S, Kurashige C, Mishima T, Tsujikawa K, Okamoto H, Majima M.

Lab Invest. 2020 Jan 7. doi: 10.1038/s41374-019-0364-0. [Epub ahead of print]

PMID:
31911634
14.

Comparison of long-term outcomes between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma.

Zhao H, Koyanagi K, Kato K, Ito Y, Itami J, Igaki H, Tachimori Y.

J Thorac Dis. 2019 Nov;11(11):4654-4662. doi: 10.21037/jtd.2019.10.31.

15.

Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.

Ito Y, Miyauchi A.

Expert Rev Endocrinol Metab. 2020 Jan 6:1-8. doi: 10.1080/17446651.2020.1707078. [Epub ahead of print]

PMID:
31902250
16.

Complication rate, cure rate, and long-term outcomes of microsurgery for intracranial dural arteriovenous fistulae: a multicenter series and systematic review.

Sugiyama T, Nakayama N, Ushikoshi S, Kazumata K, Okamoto M, Ito M, Osanai T, Shimoda Y, Uchida K, Shimbo D, Ito Y, Asaoka K, Nakamura T, Kuroda S, Houkin K.

Neurosurg Rev. 2020 Jan 2. doi: 10.1007/s10143-019-01232-y. [Epub ahead of print]

PMID:
31897884
17.

Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK-positive anaplastic large-cell lymphoma refractory to chemotherapy and brentuximab vedotin.

Nakai R, Fukuhara S, Maeshima AM, Kim SW, Ito Y, Hatta S, Suzuki T, Yuda S, Makita S, Munakata W, Suzuki T, Maruyama D, Izutsu K.

Clin Case Rep. 2019 Nov 15;7(12):2500-2504. doi: 10.1002/ccr3.2543. eCollection 2019 Dec.

18.

Cat and Dog Ownership in Early Life and Infant Development: A Prospective Birth Cohort Study of Japan Environment and Children's Study.

Minatoya M, Araki A, Miyashita C, Itoh S, Kobayashi S, Yamazaki K, Ait Bamai Y, Saijyo Y, Ito Y, Kishi R, The Japan Environment And Children's Study Group.

Int J Environ Res Public Health. 2019 Dec 27;17(1). pii: E205. doi: 10.3390/ijerph17010205.

19.

A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab.

Ito K, Oguri T, Takeda N, Fukumitsu K, Fukuda S, Kanemitsu Y, Tajiri T, Ohkubo H, Takemura M, Maeno K, Ito Y, Niimi A.

Respir Med Case Rep. 2019 Dec 10;29:100979. doi: 10.1016/j.rmcr.2019.100979. eCollection 2020.

20.

Direct in vitro and in vivo demonstration of muscarinic receptor binding by the novel radioligand, [3H]5-hydroxymethyltolterodine, in the bladder and other tissues of rats.

Yamada S, Kuraoka S, Ito Y, Kagota S, Shinozuka K, Onoue S.

J Pharmacol Sci. 2019 Dec 11. pii: S1347-8613(19)35740-8. doi: 10.1016/j.jphs.2019.12.004. [Epub ahead of print]

21.

Analysis of treatment process time for real-time-image gated-spot-scanning proton-beam therapy (RGPT) system.

Yoshimura T, Shimizu S, Hashimoto T, Nishioka K, Katoh N, Inoue T, Taguchi H, Yasuda K, Matsuura T, Takao S, Tamura M, Ito YM, Matsuo Y, Tamura H, Horita K, Umegaki K, Shirato H.

J Appl Clin Med Phys. 2019 Dec 30. doi: 10.1002/acm2.12804. [Epub ahead of print]

PMID:
31886616
22.

C-Mannosyl tryptophan increases in the plasma of patients with ovarian cancer.

Iwahashi N, Inai Y, Minakata S, Sakurai S, Manabe S, Ito Y, Ino K, Ihara Y.

Oncol Lett. 2020 Jan;19(1):908-916. doi: 10.3892/ol.2019.11161. Epub 2019 Nov 28.

23.

Effects of Edaravone on Nitric Oxide, Hydroxyl Radicals and Neuronal Nitric Oxide Synthase During Cerebral Ischemia and Reperfusion in Mice.

Kawasaki H, Ito Y, Kitabayashi C, Tanaka A, Nishioka R, Yamazato M, Ishizawa K, Nagai T, Hirayama M, Takahashi K, Yamamoto T, Araki N.

J Stroke Cerebrovasc Dis. 2019 Dec 25:104531. doi: 10.1016/j.jstrokecerebrovasdis.2019.104531. [Epub ahead of print]

PMID:
31882337
24.

Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017.

Nakano S, Fujisawa T, Ito Y, Chang B, Matsumura Y, Yamamoto M, Suga S, Ohnishi M, Nagao M.

Vaccine. 2019 Dec 24. pii: S0264-410X(19)31664-0. doi: 10.1016/j.vaccine.2019.12.022. [Epub ahead of print]

PMID:
31882246
25.

Comparison of Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Co-Transporter 2 Inhibitors Between Japanese and Non-Japanese Patients: A Meta-Analysis.

Ito Y, Ambe K, Hayase T, Kobayashi M, Tohkin M.

Clin Transl Sci. 2019 Dec 27. doi: 10.1111/cts.12732. [Epub ahead of print]

PMID:
31880866
26.

Association between Gait Deviation Index and Physical Function in Children with Bilateral Spastic Cerebral Palsy: A Cross-Sectional Study.

Ito T, Noritake K, Sugiura H, Kamiya Y, Tomita H, Ito Y, Sugiura H, Ochi N, Yoshihashi Y.

J Clin Med. 2019 Dec 20;9(1). pii: E28. doi: 10.3390/jcm9010028.

27.

The Advent of Studies on Jaw Cysts with Keratinization: A Review of Overlooked Papers on Odontogenic Keratocyst and Orthokeratinized Odontogenic Cyst.

Ide F, Ito Y, Muramatsu T, Miyazaki Y, Nishimura M, Kikuchi K, Kusama K.

Head Neck Pathol. 2019 Dec 23. doi: 10.1007/s12105-019-01115-0. [Epub ahead of print]

PMID:
31873934
28.

Wide visual field angle holographic display using compact electro-holographic projectors.

Ito Y, Mitobe M, Nagahama M, Sakai H, Sakamoto Y.

Appl Opt. 2019 Dec 1;58(34):G135-G142. doi: 10.1364/AO.58.00G135.

PMID:
31873494
29.

Inhibition of Calcineurin and Glycogen Synthase Kinase-3β by Ricinoleic Acid Derived from Castor Oil.

Yoshida J, Okawa Y, Oyama T, Shimoda N, Uesugi S, Takagi H, Ito Y, Kimura KI.

Lipids. 2019 Dec 22. doi: 10.1002/lipd.12208. [Epub ahead of print]

PMID:
31867745
30.

Prediction of the Cerebral Hyperperfusion Phenomenon after Carotid Endarterectomy Using a Transit Time Flowmeter.

Matsumura H, Ito Y, Uemura K, Nakai Y, Komatsu Y, Ishikawa E, Matsumaru Y, Matsumura A.

Neurol Med Chir (Tokyo). 2019 Dec 21. doi: 10.2176/nmc.oa.2019-0114. [Epub ahead of print]

31.

The Long-Term Efficacy of Cochlear Implantation for Hearing Loss in Muckel-Wells Syndrome.

Ogawa B, Aoki M, Ohnishi H, Ohashi T, Hayashi H, Kuze B, Ito Y.

J Int Adv Otol. 2019 Dec;15(3):454-458. doi: 10.5152/iao. 2019.6871.

32.

Clinical efficacy of optical coherence tomography-guided versus intravascular ultrasound-guided rotational atherectomy for calcified coronary lesion.

Kobayashi N, Ito Y, Yamawaki M, Araki M, Obokata M, Sakamoto Y, Mori S, Tsutsumi M, Honda Y, Makino K, Shirai S, Mizusawa M, Hirano K.

EuroIntervention. 2019 Dec 17. pii: EIJ-D-19-00725. doi: 10.4244/EIJ-D-19-00725. [Epub ahead of print]

33.

Auditory-induced visual illusions in rodents measured by spontaneous behavioural response.

Ito Y, Sato R, Tamai Y, Hiryu S, Uekita T, Kobayasi KI.

Sci Rep. 2019 Dec 16;9(1):19211. doi: 10.1038/s41598-019-55664-z.

34.

Tubulointerstitial nephritis with monotypic lympho-plasmacytic infiltrates in a patient with primary Sjögren's syndrome accompanied by IgA-type monoclonal gammopathy.

Saeki T, Kuroha T, Sato Y, Tamura M, Iguchi A, Ito T, Yamazaki H, Ito Y, Yoshita K, Imai N, Narita I, Usuda H.

BMC Nephrol. 2019 Dec 12;20(1):464. doi: 10.1186/s12882-019-1646-x.

35.

Reliability and validity of a Japanese version of the psychosocial assessment tool for families of children with cancer.

Tsumura A, Okuyama T, Ito Y, Kondo M, Saitoh S, Kamei M, Sato I, Ishida Y, Kato Y, Takeda Y, Akechi T.

Jpn J Clin Oncol. 2019 Dec 13. pii: hyz181. doi: 10.1093/jjco/hyz181. [Epub ahead of print]

PMID:
31836884
36.

Developmental exposure to diacetoxyscirpenol reversibly disrupts hippocampal neurogenesis by inducing oxidative cellular injury and suppressed differentiation of granule cell lineages in mice.

Nakajima K, Ito Y, Kikuchi S, Okano H, Takashima K, Woo GH, Yoshida T, Yoshinari T, Sugita-Konishi Y, Shibutani M.

Food Chem Toxicol. 2019 Dec 10;136:111046. doi: 10.1016/j.fct.2019.111046. [Epub ahead of print]

37.

Carboplatin-related acute interstitial nephritis in a patient with pancreatic neuroendocrine tumor.

Asai A, Katsuno T, Yamaguchi M, Iwagaitsu S, Nobata H, Kinashi H, Kitamura H, Banno S, Ito Y.

CEN Case Rep. 2019 Dec 13. doi: 10.1007/s13730-019-00437-w. [Epub ahead of print]

38.

Stretching of fibroblast cells on micropatterned gelatin on silicone elastomer.

Müller S, Ueda M, Isoshima T, Ushida T, Ito Y.

J Mater Chem B. 2019 Dec 13. doi: 10.1039/c9tb02203a. [Epub ahead of print]

PMID:
31833527
39.

Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.

Takeda T, Tin AL, Corradi RB, Alvim R, Hashimoto T, Ito Y, Nguyen DP, Mamoor M, Robertson NL, Vargas HA, Benfante NE, Sjoberg DD, Eastham JA, Scardino PT, Fine SW, Oya M, Touijer KA.

Int J Urol. 2019 Dec 13. doi: 10.1111/iju.14161. [Epub ahead of print]

PMID:
31833113
40.

The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapy.

Dekura Y, Nishioka K, Hashimoto T, Miyamoto N, Suzuki R, Yoshimura T, Matsumoto R, Osawa T, Abe T, Ito YM, Shinohara N, Shirato H, Shimizu S.

Radiat Oncol. 2019 Dec 12;14(1):226. doi: 10.1186/s13014-019-1424-8.

41.

Intracellular build-up RNAi with single-strand circular RNAs as siRNA precursors.

Kimura Y, Shu Z, Ito M, Abe N, Nakamoto K, Tomoike F, Shuto S, Ito Y, Abe H.

Chem Commun (Camb). 2020 Jan 2;56(3):466-469. doi: 10.1039/c9cc04872c.

PMID:
31828267
42.

Biomonitoring method for neonicotinoid insecticides in urine of non-toilet-trained children using LC-MS/MS.

Ueyama J, Aoi A, Ueda Y, Oya N, Sugiura Y, Ito Y, Ebara T, Kamijima M.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2019 Dec 11:1-12. doi: 10.1080/19440049.2019.1696020. [Epub ahead of print]

PMID:
31825743
43.

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.

Modi S, Saura C, Yamashita T, Park YH, Kim SB, Tamura K, Andre F, Iwata H, Ito Y, Tsurutani J, Sohn J, Denduluri N, Perrin C, Aogi K, Tokunaga E, Im SA, Lee KS, Hurvitz SA, Cortes J, Lee C, Chen S, Zhang L, Shahidi J, Yver A, Krop I; DESTINY-Breast01 Investigators.

N Engl J Med. 2019 Dec 11. doi: 10.1056/NEJMoa1914510. [Epub ahead of print]

PMID:
31825192
44.

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.

Yoshimitsu M, Fuji S, Utsunomiya A, Nakano N, Ito A, Ito Y, Miyamoto T, Suehiro Y, Kawakita T, Moriuchi Y, Nakamae H, Kanda Y, Ichinohe T, Fukuda T, Atsuta Y, Kato K; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Dec 9. pii: S1083-8791(19)30839-0. doi: 10.1016/j.bbmt.2019.12.004. [Epub ahead of print]

PMID:
31821886
45.

The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.

Honda Y, Araki M, Yamawaki M, Hirano K, Kobayashi N, Sakamoto Y, Mori S, Tsutsumi M, Makino K, Ito Y.

Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610. [Epub ahead of print]

PMID:
31815366
46.

Pyogenic sacroiliitis caused by pneumococcal serotype 16F in a child.

Yamada Y, Yamaguchi H, Ito Y, Takeuchi N, Kasai M.

Pediatr Int. 2019 Dec;61(12):1267-1268. doi: 10.1111/ped.14034. Epub 2019 Dec 8. No abstract available.

PMID:
31814206
47.

Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study.

Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S.

Breast Cancer. 2019 Dec 6. doi: 10.1007/s12282-019-01029-3. [Epub ahead of print]

PMID:
31811519
48.

Multipotent Neurotrophic Effects of Hepatocyte Growth Factor in Spinal Cord Injury.

Yamane K, Misawa H, Takigawa T, Ito Y, Ozaki T, Matsukawa A.

Int J Mol Sci. 2019 Dec 2;20(23). pii: E6078. doi: 10.3390/ijms20236078. Review.

49.

FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.

Isono Y, Furuya M, Kuwahara T, Sano D, Suzuki K, Jikuya R, Mitome T, Otake S, Kawahara T, Ito Y, Muraoka K, Nakaigawa N, Kimura Y, Baba M, Nagahama K, Takahata H, Saito I, Schmidt LS, Linehan WM, Kodama T, Yao M, Oridate N, Hasumi H.

Biochem Biophys Res Commun. 2019 Dec 2. pii: S0006-291X(19)32312-5. doi: 10.1016/j.bbrc.2019.11.184. [Epub ahead of print]

PMID:
31806376
50.

Discovery of specialized NK cell populations infiltrating human melanoma metastases.

de Andrade LF, Lu Y, Luoma A, Ito Y, Pan D, Pyrdol JW, Yoon CH, Yuan GC, Wucherpfennig KW.

JCI Insight. 2019 Dec 5;4(23). pii: 133103. doi: 10.1172/jci.insight.133103.

Supplemental Content

Support Center